Results 101 to 110 of about 885 (156)

Head-to-Head in Heart Failure: Comparative Insights on Empagliflozin and Dapagliflozin. [PDF]

Biomedicines
Cozma D, Văcărescu C, Stoicescu C.
europepmc   +1 more source

Empagliflozin and Colchicine in Patients With Reduced Left Ventricular Ejection Fraction Following ST-Elevation Myocardial Infarction: A Systematic Review. [PDF]

Cureus
Asante Baadu F, Arif MA, Riaz Z, Argariya M, Rani K, Iqbal M.   +5 more
europepmc   +1 more source

Multiplexed tumor profiling with generative AI accelerates histopathology workflows and improves clinical predictions

, 2023
Rapsomaniki MA, Pati P, Karkampouna S, Bonollo F, Comperat E, Radic M, Spahn M, Martinelli A, Wartenberg M, Julio MK.   +9 more
europepmc   +2 more sources

Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling. [PDF]

Nat Mach Intell
Pati P, Karkampouna S, Bonollo F, Compérat E, Radić M, Spahn M, Martinelli A, Wartenberg M, Kruithof-de Julio M, Rapsomaniki M.   +9 more
europepmc   +1 more source

Sodium-Glucose Cotransporter-2 Inhibitors in Anthracycline-Treated Cancer Patients: A Narrative Review of Emerging Cardioprotective Evidence. [PDF]

Cureus
Nabhan E, Vana AP, Khouri R, Naoum Nehme E, Poulos N.   +4 more
europepmc   +1 more source

Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists. [PDF]

Pharmaceuticals (Basel)
Cosentino N, Trombara F, De Metrio M, Molinari C, Genovese S, Pontone G, Marenzi G.   +6 more
europepmc   +1 more source

Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study. [PDF]

Medicina (Kaunas)
Mateoc T, Suciu IM, Gaiță D, Minodora A, Popescu R, Vlad T, Flangea C, Muntean C, Vlad DC.   +8 more
europepmc   +1 more source

Using the Power Wheel as a transformative tool to promote equity through spaces and places of patient engagement. [PDF]

BMJ Open
Sayani A, Cordeaux E, Wu K, Awil F, Garcia V, Hinds R, Jeji T, Khan O, Soh BL, Mensah D, Monteith L, Musawi M, Rathbone M, Robinson J, Sterling S, Wardak D, Amsdr I, Khawari M, Niwe S, Hussain A, Forster V, Maybee A.   +21 more
europepmc   +1 more source

Reply: Balancing Promise and Evidence: Critical Perspectives on SGLT2 Inhibitors for Cardiotoxicity Prevention. [PDF]

JACC CardioOncol
Bhatti AW, Makwana B, Khadke S, Dani SS, Ganatra S.   +4 more
europepmc   +1 more source

Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort. [PDF]

Eur Urol Open Sci
Giesen A, Milonas D, Laenen A, Tosco L, Chlosta P, De Meerleer G, Devos G, Everaerts W, Graefen M, Gratzke C, Marchioro G, Sanchez-Salas R, Tombal B, Van Der Poel H, Van Poppel H, Venclovas Z, Briganti A, Gontero P, Karnes JR, Spahn M, Joniau S, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT).   +21 more
europepmc   +1 more source